Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
127M
-
Number of holders
-
51
-
Total 13F shares, excl. options
-
4.04M
-
Shares change
-
+2.15M
-
Total reported value, excl. options
-
$19.4M
-
Value change
-
+$10M
-
Number of buys
-
35
-
Number of sells
-
-8
-
Price
-
$4.81
Significant Holders of Organogenesis Holdings Inc. - Common Stock, $0.01 par value (ORGO) as of Q4 2019
56 filings reported holding ORGO - Organogenesis Holdings Inc. - Common Stock, $0.01 par value as of Q4 2019.
Organogenesis Holdings Inc. - Common Stock, $0.01 par value (ORGO) has 51 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.04M shares
of 127M outstanding shares and own 3.19% of the company stock.
Largest 10 shareholders include BlackRock Inc. (628K shares), Prosight Management, LP (618K shares), VANGUARD GROUP INC (262K shares), GRANAHAN INVESTMENT MANAGEMENT INC/MA (250K shares), HUSSMAN STRATEGIC ADVISORS, INC. (200K shares), GEODE CAPITAL MANAGEMENT, LLC (199K shares), Worth Venture Partners, LLC (168K shares), STATE STREET CORP (165K shares), MILLENNIUM MANAGEMENT LLC (162K shares), and NORTHERN TRUST CORP (153K shares).
This table shows the top 51 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.